Loading company…
Skyline Diagnostics, founded in 2005 in Rotterdam, develops microarray-based diagnostic tests for oncology.
Founded in 2005 and based in Rotterdam, the Netherlands, Skyline Diagnostics works on discovering and developing microarray-based diagnostic tests that use molecular signatures for personalized medicine in oncology. The listed stage is Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in